DK1268844T3 - Modulering af fremstilling af pneumococcus kapselformigt polysaccharid - Google Patents

Modulering af fremstilling af pneumococcus kapselformigt polysaccharid

Info

Publication number
DK1268844T3
DK1268844T3 DK01918754T DK01918754T DK1268844T3 DK 1268844 T3 DK1268844 T3 DK 1268844T3 DK 01918754 T DK01918754 T DK 01918754T DK 01918754 T DK01918754 T DK 01918754T DK 1268844 T3 DK1268844 T3 DK 1268844T3
Authority
DK
Denmark
Prior art keywords
modulation
preparation
capsular polysaccharide
test compound
pneumococcus
Prior art date
Application number
DK01918754T
Other languages
Danish (da)
English (en)
Inventor
Jeffrey N Weiser
Original Assignee
Philadelphia Children Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22699002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1268844(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Philadelphia Children Hospital filed Critical Philadelphia Children Hospital
Application granted granted Critical
Publication of DK1268844T3 publication Critical patent/DK1268844T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK01918754T 2000-03-16 2001-03-16 Modulering af fremstilling af pneumococcus kapselformigt polysaccharid DK1268844T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18984700P 2000-03-16 2000-03-16
PCT/US2001/008442 WO2001068903A1 (en) 2000-03-16 2001-03-16 Modulating production of pneumococcal capsular polysaccharide

Publications (1)

Publication Number Publication Date
DK1268844T3 true DK1268844T3 (da) 2009-11-16

Family

ID=22699002

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01918754T DK1268844T3 (da) 2000-03-16 2001-03-16 Modulering af fremstilling af pneumococcus kapselformigt polysaccharid

Country Status (19)

Country Link
US (1) US6642017B2 (ko)
EP (2) EP1268844B1 (ko)
JP (1) JP4856345B2 (ko)
KR (3) KR20080081978A (ko)
CN (2) CN101586143A (ko)
AT (1) ATE437955T1 (ko)
AU (2) AU2001245795B2 (ko)
BR (1) BRPI0109293B8 (ko)
CA (1) CA2403001C (ko)
CY (1) CY1109418T1 (ko)
DE (1) DE60139384D1 (ko)
DK (1) DK1268844T3 (ko)
ES (1) ES2330919T3 (ko)
HK (1) HK1055448A1 (ko)
IL (3) IL151772A0 (ko)
MX (1) MXPA02009047A (ko)
NZ (1) NZ521343A (ko)
PT (1) PT1268844E (ko)
WO (1) WO2001068903A1 (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1268844B1 (en) * 2000-03-16 2009-07-29 The Children's Hospital Of Philadelphia Modulating production of pneumococcal capsular polysaccharide
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7718791B2 (en) * 2005-04-08 2010-05-18 Wyeth Llc Separation of contaminants from Streptococcus pneumoniae polysaccharide by pH manipulation
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
RU2460539C2 (ru) * 2006-10-10 2012-09-10 Вайет СПОСОБ ОЧИСТКИ ПОЛИСАХАРИДОВ Streptococcus pneumoniae 3 ТИПА (ВАРИАНТЫ)
WO2009059054A2 (en) * 2007-10-30 2009-05-07 The Trustees Of The University Of Pennsylvania Bacteria strains an d bacteriocin produced therefrom
DK2379734T3 (en) * 2008-12-18 2018-04-23 Wyeth Llc Method for Controlling the Molecular Weight of Polysaccharide of Streptococcus Pneumoniae Serotype 19A
PL2385981T3 (pl) * 2008-12-18 2020-01-31 Wyeth Llc Sposób kontroli masy cząsteczkowej polisacharydów streptococcus pneumoniae z zastosowaniem węgla
CN102093963B (zh) * 2010-11-26 2012-11-14 兰州生物制品研究所有限责任公司 富含磷壁酸的肺炎链球菌的培养方法
US9975801B2 (en) 2014-07-31 2018-05-22 Corning Incorporated High strength glass having improved mechanical characteristics
WO2015169774A1 (en) * 2014-05-07 2015-11-12 Glaxosmithkline Biologicals S.A. Purification of secreted polysaccharides from s. agalactiae
US11097974B2 (en) 2014-07-31 2021-08-24 Corning Incorporated Thermally strengthened consumer electronic glass and related systems and methods
US10611664B2 (en) 2014-07-31 2020-04-07 Corning Incorporated Thermally strengthened architectural glass and related systems and methods
WO2017123573A2 (en) 2016-01-12 2017-07-20 Corning Incorporated Thin thermally and chemically strengthened glass-based articles
US11795102B2 (en) 2016-01-26 2023-10-24 Corning Incorporated Non-contact coated glass and related coating system and method
WO2019040818A2 (en) 2017-08-24 2019-02-28 Corning Incorporated GLASSES HAVING ENHANCED TEMPERATURE CAPABILITIES
TWI785156B (zh) 2017-11-30 2022-12-01 美商康寧公司 具有高熱膨脹係數及對於熱回火之優先破裂行為的非離子交換玻璃
EP3744829A4 (en) * 2018-01-22 2021-10-27 The Research Foundation For Microbial Diseases Of Osaka University MEDIUM FOR GROWING PNEUMOCOCCAL SAMPLES
CN114514115B (zh) 2019-08-06 2023-09-01 康宁股份有限公司 具有用于阻止裂纹的埋入式应力尖峰的玻璃层压体及其制造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510606A1 (fr) * 1981-07-30 1983-02-04 Berri Balzac Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins
CA2116261A1 (en) * 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a
EP0804582A1 (en) * 1994-05-16 1997-11-05 The Uab Research Foundation $i(STREPTOCOCCUS PNEUMONIAE) CAPSULAR POLYSACCHARIDE GENES AND FLANKING REGIONS
EP1268844B1 (en) * 2000-03-16 2009-07-29 The Children's Hospital Of Philadelphia Modulating production of pneumococcal capsular polysaccharide

Also Published As

Publication number Publication date
EP1268844A1 (en) 2003-01-02
ES2330919T3 (es) 2009-12-17
IL191962A0 (en) 2008-12-29
KR20080081978A (ko) 2008-09-10
AU4579501A (en) 2001-09-24
KR20080036656A (ko) 2008-04-28
DE60139384D1 (de) 2009-09-10
MXPA02009047A (es) 2005-04-19
US20030021811A1 (en) 2003-01-30
NZ521343A (en) 2005-03-24
CA2403001A1 (en) 2001-09-20
ATE437955T1 (de) 2009-08-15
IL151772A0 (en) 2003-04-10
CN101586143A (zh) 2009-11-25
PT1268844E (pt) 2009-11-03
IL151772A (en) 2009-12-24
CA2403001C (en) 2012-07-03
CN1429276A (zh) 2003-07-09
JP4856345B2 (ja) 2012-01-18
KR100942738B1 (ko) 2010-02-17
BRPI0109293B1 (pt) 2015-05-19
HK1055448A1 (en) 2004-01-09
EP1967591A2 (en) 2008-09-10
KR100914702B1 (ko) 2009-08-28
JP2003531584A (ja) 2003-10-28
AU2001245795B2 (en) 2005-07-28
BRPI0109293B8 (pt) 2021-05-25
EP1967591A3 (en) 2008-12-03
BR0109293A (pt) 2003-06-10
KR20030040196A (ko) 2003-05-22
IL191962A (en) 2010-12-30
EP1268844A4 (en) 2006-03-29
WO2001068903A1 (en) 2001-09-20
US6642017B2 (en) 2003-11-04
CY1109418T1 (el) 2014-08-13
EP1268844B1 (en) 2009-07-29
CN100529054C (zh) 2009-08-19

Similar Documents

Publication Publication Date Title
DK1268844T3 (da) Modulering af fremstilling af pneumococcus kapselformigt polysaccharid
CY1117551T1 (el) Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου
ATE419005T1 (de) Staphylococcus aureus exopolysaccharid und verfahren
ATE503837T1 (de) Hybride expression neisserscher proteine
TR200000338T2 (tr) Polietilen'in hazırlanmasına mahsus bir yöntem.
ATE410800T1 (de) Anordnung, umfassend einen ph-sensor und einen steckverbinder
DE69919754D1 (de) Verwendung von aufgereinigtem invaplex als impfstoff für gram-negativebakterien
DE60122016D1 (de) Resorcinderivat für kautschukmassen
NO993694L (no) Sylfonylurea- og adjuvansbaserte faste blandinger
DE50003906D1 (de) Elektrischer Steckverbinder sowie Gehäuse für einen solchen elektrischen Steckverbinder
ATE445839T1 (de) Latentes tuberkulose-diagnostisches antigen und verwendungsmethode
NZ326675A (en) Oxazoline arthropodicides
EA200200435A1 (ru) Анализ лептина
DK101196A (da) Histaminderivat, histamin-immunogen-konjugat samt antistof fremstillet mod konjugatet
DK0992512T3 (da) Reduceret cortisolkonjugat
TR200300942T1 (tr) Elektrikli süpürge
NO981340L (no) Stabiliserte fosfolipidsammensetninger
DK192890D0 (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
ID28174A (id) Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya
ATE420104T1 (de) Antigen
DK0570682T3 (da) Syntetiske lipid-A-glycoconjugat-antigener til anvendelse i vacciner
CO5241277A1 (es) Vacuna
ES1043546U (es) Junta vertical para bloques utilizables en fabrica armada.
UA38876A (uk) Спосіб профілактики ускладнень віддалених нейропатій, викликаних нейропаралітичними фосфороорганічними речовинами
RU99102930A (ru) Способ оценки противодифтерийного и противостолбнячного иммунитета у взрослого населения крайнего севера